Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
作者信息
Klintmalm G B, Goldstein R, Gonwa T, Wiesner R H, Krom R A, Shaw B W, Stratta R, Ascher N L, Roberts J W, Lake J
机构信息
Baylor University Medical Center, Dallas, Texas.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
PMID:7679828
Abstract
摘要
相似文献
1
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.肝移植后难治性排斥反应从环孢素转换为基于FK 506的免疫抑制治疗成功的预后因素。美国多中心FK 506肝脏研究组。
Transplant Proc. 1993 Feb;25(1 Pt 1):641-3.
2
3
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Transplant Proc. 1995 Feb;27(1):45-9.
4
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Transplant Proc. 1996 Apr;28(2):1008-10.
5
6
Clinical use of FK 506 in liver transplantation.
Transplant Proc. 1996 Apr;28(2):974-6.
7
8
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].[肝移植后免疫抑制治疗中他克莫司（FK 506）与环孢素的比较]
Z Gastroenterol. 1995 Oct;33(10):624-5.
9
Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.小儿肾移植受者从环孢素转换为他克莫司的情况。
Pediatr Nephrol. 2002 Aug;17(8):664-7. doi: 10.1007/s00467-002-0870-x. Epub 2002 Jun 7.
10
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Transplant Proc. 1995 Feb;27(1):1121-3.
引用本文的文献
1
A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results.一项关于他克莫司（FK 506）用于临床心脏移植的前瞻性试验：中期结果。
J Thorac Cardiovasc Surg. 1996 Apr;111(4):764-72. doi: 10.1016/s0022-5223(96)70336-7.
2
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
Zotero 插件